School of Pharmacy, Department of Pharmacology and Clinical Pharmacy, Addis Ababa University, College of Health Sciences, Addis Ababa, Ethiopia
Pharmaceuticals and Medical Equipment Directorate, Ethiopia Ministry of Health, Addis Ababa, Ethiopia.
BMJ Open. 2022 Feb 11;12(2):e054541. doi: 10.1136/bmjopen-2021-054541.
Effective antimicrobial containment strategies such as Antimicrobial Stewardship Programs (ASPs) require comprehensive data on antibiotics use which are scarce in Ethiopia. This study sought to assess antibiotics use and healthcare-associated infections (HCAIs) in Ethiopian public hospitals.
We conducted a cross-sectional study using the WHO point-prevalence survey protocol for systemic antibiotics use and HCAIs for low/middle-income countries.
The study was conducted among 10 public hospitals in 2021.
All patients admitted to adult and paediatric inpatient and emergency wards before or at 08:00 on the survey date were enrolled.
The primary outcome measures were the prevalence of antibiotic use, HCAIs and the hospitals' readiness to implement ASP.
Data were collected from 1820 patient records. None of the surveyed hospitals had functional ASP. The common indication for antibiotics was for HCAIs (40.3%). Pneumonia was the most common bacterial infection (28.6%) followed by clinical sepsis (17.8%). Most treatments were empiric (96.7%) and the overall prevalence of antibiotic use was 63.8% with antibiotics prescription per patient ratio of 1.77. Ceftriaxone was the most commonly prescribed antibiotic (30.4%) followed by metronidazole (15.4%). Age, having HIV infection, ward type, type of hospital, catheterisation and intubation history had significant association with antibiotic use. Patients who were treated in paediatric surgical wards were about four times more likely to be on antibiotics compared with patients treated at an adult emergency ward. Patients on urinary catheter (adjusted OR (AOR)=2.74, 95% CI: 2.04 to 3.68) and intubation device (AOR=2.62, 95% CI: 1.02 to 6.76) were more likely to be on antibiotics than their non-intubated/non-catheterised counterparts. Patients treated at secondary-level hospitals had 0.34 times lower odds of being on antibiotics compared with those in tertiary hospitals.
Antibiotic use across the surveyed hospitals was common and most were empiric which has both practical and policy implications for strengthening ASP and promoting rational antibiotics use.
有效的抗菌药物管控策略,如抗菌药物管理计划(Antimicrobial Stewardship Programs,ASPs),需要对抗生素的使用进行全面的数据评估,但在埃塞俄比亚,这方面的数据非常匮乏。本研究旨在评估埃塞俄比亚公立医院的抗生素使用和与医疗保健相关的感染(Healthcare-Associated Infections,HCAIs)情况。
我们采用世界卫生组织针对中低收入国家的系统抗生素使用和 HCAIs 进行的点患病率调查方案,进行了一项横断面研究。
该研究于 2021 年在 10 家公立医院进行。
在调查日 08:00 之前或之时被收入成人和儿科住院和急诊病房的所有住院患者均被纳入研究。
主要结局指标为抗生素使用、HCAIs 的流行情况以及医院实施 ASP 的准备情况。
共收集了 1820 份患者病历。没有一家被调查的医院有功能齐全的 ASP。抗生素使用的常见指征是 HCAIs(40.3%)。肺炎是最常见的细菌感染(28.6%),其次是临床败血症(17.8%)。大多数治疗是经验性的(96.7%),抗生素的总体使用率为 63.8%,每位患者的抗生素处方比例为 1.77。头孢曲松是最常用的抗生素(30.4%),其次是甲硝唑(15.4%)。年龄、HIV 感染、病房类型、医院类型、导管插入和插管史与抗生素使用有显著关联。与在成人急诊病房接受治疗的患者相比,在儿科外科病房接受治疗的患者使用抗生素的可能性约高四倍。使用导尿管(调整后的比值比(Adjusted OR,AOR)=2.74,95%置信区间(Confidence Interval,CI):2.04 至 3.68)和插管设备(AOR=2.62,95%CI:1.02 至 6.76)的患者更有可能使用抗生素,而非未插管/未置管的患者。与三级医院相比,二级医院治疗的患者使用抗生素的可能性低 0.34 倍。
在所调查的医院中,抗生素的使用非常普遍,而且大多数都是经验性的,这对加强 ASP 和促进合理使用抗生素具有实际和政策意义。